Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pro Medicus Limited ( (AU:PME) ) has shared an announcement.
Pro Medicus Limited has announced its Annual General Meeting (AGM) scheduled for November 24, 2025, which will be conducted as a hybrid meeting. Shareholders can participate in person or online, with provisions made for voting and asking questions through a dedicated portal. This meeting is crucial for stakeholders to engage with the company’s board and discuss resolutions, reflecting Pro Medicus’s commitment to transparency and shareholder engagement.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$317.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software and services. The company focuses on delivering innovative solutions for medical imaging, catering to healthcare providers and institutions globally.
Average Trading Volume: 172,560
Technical Sentiment Signal: Buy
Current Market Cap: A$29.98B
Learn more about PME stock on TipRanks’ Stock Analysis page.